DAM
DMIIR

DLD Asset Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

DLD Asset Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.98K Hold
112,200
– – ﹤0.01% 344
2025
Q4 		$15.7K Buy
+112,200
New +$16K ﹤0.01% 359

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

DLD Asset Management's DMIIR Position: Q1 2026 in Review

DLD Asset Management held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q1 2026 at 112,200 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

DLD Asset Management first reported a position in DMIIR in Q4 2025 and has held it in 2 quarters since. The position peaked at $15.7K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • DLD Asset Management held 112,200 shares of Drugs Made In America Acquisition II Corp Right worth $8.98K as of Q1 2026.
  • DLD Asset Management left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q1 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of DLD Asset Management's portfolio in Q1 2026, its #344 holding.
  • DLD Asset Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 2 quarters since.
  • DLD Asset Management's Drugs Made In America Acquisition II Corp Right position peaked at $15.7K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.